Summary
The U.S. Food and Drug Administration (FDA) has approved the first oral GLP-1 pill for weight loss. The pill is called Wegovy and is made by Novo Nordisk. It helps people lose weight and maintain weight loss and may also reduce risks related to heart problems.
Key Facts
- The FDA approved the first oral glucagon-like peptide-1 (GLP-1) pill for weight loss.
- The pill is named Wegovy and contains 25 mg of semaglutide.
- It is taken once daily.
- The pill is meant to help people lose weight and keep it off.
- It might also help lower the risk of serious heart issues.
- In a trial called OASIS 4, participants lost an average of 16.6% of their body weight when they followed the treatment.
